Atlas Trials

Respiratory Disorders

30 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Respiratory Disorders

RecordFirmDate
Study to Assess the Immunogenicity and Safety of GSK's Investigational Vaccine (GSK3277511A) When Given to Healthy Smokers and Ex-smokers After Administration of Shingrix Vaccine (NCT03894969)GlaxoSmithKline2019-04-23
A Study to Test if a Third Dose of the Vaccine is Safe in Current and Former Smokers Aged 40 to 80 Years Old and to Gather Information on the Immune Response Following the Third Dose of the Vaccine (NCT03443427)GlaxoSmithKline2018-03-20
A Study to Test if the Vaccine is Working Well in Chronic Obstructive Pulmonary Disease (COPD) Patients Aged 40 to 80 Years Old to Reduce Episodes of Worsening Symptoms and to Gather Further Information on Safety and Immune Response. (NCT03281876)GlaxoSmithKline2017-11-27
Ventilator Hyperinflation and Hemodynamics (NCT03557645)Centro Universitário Augusto Motta2017-11-05
Occurrence of Potential Bacterial and Viral Pathogens in Stable Chronic Obstructive Pulmonary Disease and During Acute Exacerbations of the Disease, in Asia Pacific (NCT03151395)GlaxoSmithKline2017-08-25
A Long Term Follow-up Study up to 4 Years After Study Vaccination to Assess Immunogenicity and Safety of the Investigational Vaccine in Adults (NCT03201211)GlaxoSmithKline2017-06-22
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of the Investigational GSK Biologicals' GSK3277511A Vaccine in Adults. (NCT02547974)GlaxoSmithKline2015-08-31
Bioequivalence of GW483100 10 Milligram (mg) Tablets in Healthy Subjects Under Fasting Conditions (NCT02658422)GlaxoSmithKline2015-08-18
Relative Bioavailability Study of Two Montelukast Sodium (GW483100) 5 Milligrams (mg) Chewable Tablets and One Reference Montelukast Sodium 5 mg Chewable Tablet in Healthy Adult Subjects (NCT02322671)GlaxoSmithKline2015-02-23
Use of Hyperpolarized 129Xe MR Lung Imaging in Adults for Calibration (NCT02316379)Children's Hospital Medical Center, Cincinnati2015-02-01
Use of Hyperpolarized Xenon Gas for Lung Imaging in Children and Adults (NCT02272049)Children's Hospital Medical Center, Cincinnati2014-12-01
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GlaxoSmithkline (GSK) Biologicals' Investigational Vaccine GSK2838504A When Administered to Chronic Obstructive Pulmonary Disease (COPD) Patients With Persistent Airflow Obstruction. (NCT02075541)GlaxoSmithKline2014-07-08
Proprioceptive Postural Control and Diaphragm Paresis (NCT01505556)KU Leuven2014-01-01
A Study to Investigate the Safety Tolerability Pharmacokinetics, and Pharmacodynamics of Inhaled and Intravenous GSK2862277 in Healthy Volunteers (NCT01818024)GlaxoSmithKline2013-02-22
A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Non-typeable Haemophilus Influenzae (NTHi) Investigational Vaccine (GSK2838497A) in Current and Former Smokers (NCT01678677)GlaxoSmithKline2012-08-31
Safety, Reactogenicity and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Non-typeable Haemophilus Influenzae (NTHI) Vaccine (NCT01657526)GlaxoSmithKline2012-08-08
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Doses of Inhaled GSK1995057 (NCT01587807)GlaxoSmithKline2012-03-28
A Study to Assess Immunity to Specific Microbial Antigens in Healthy Smokers and Non-smokers and in Subjects With Stable COPD (NCT01516437)GlaxoSmithKline2012-02-01
Inspiratory Muscle Training and Low Back Pain (NCT01505582)KU Leuven2012-01-01
Roflumilast in Chronic Obstructive Pulmonary Disease (COPD) Patients Treated With Fixed Dose Combinations of Long-acting β2-agonist (LABA) and Inhaled Corticosteroid (ICS) (NCT01443845)AstraZeneca2011-09-30
Electrocardiographic Autonomic Function Measures in Mechanically Ventilated Patients (NCT00844935)University of California, San Francisco2011-09-01
Infectious Pathogens in Acute Respiratory Illness in Adults and Elderly (NCT01360398)GlaxoSmithKline2011-06-30
Safety Study of GSK1995057 Given as Single and Repeat Intravenous Doses in Healthy Subjects. (NCT01476046)GlaxoSmithKline2011-03-08
Timing of Planned Caesarean Section and Morbidity of the Newborn (NCT00835003)Aarhus University Hospital2009-03-01
Special Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol) (NCT01395862)GlaxoSmithKline2007-11-01
Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol) (NCT01395849)GlaxoSmithKline2007-10-01
Safety and Efficacy Study of Depelestat in Acute Respiratory Distress Syndrome (ARDS) Patients (NCT00455767)Debiopharm International SA2006-07-01

Track Respiratory Disorders automatically

Every clearance here is in the API, with alerts when new ones post.